Biodesix
BDSX
33 hedge funds and large institutions have $36.9M invested in Biodesix in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
511% more capital invested
Capital invested by funds: $6.04M → $36.9M (+$30.8M)
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
22% more funds holding
Funds holding: 27 → 33 (+6)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0.51% more ownership
Funds ownership: 0.59% → 1.11% (+0.51%)
75% less call options, than puts
Call options by funds: $2K | Put options by funds: $8K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$8.28M |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
+$3.63M |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$2.04M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$185K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$34.3K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$34K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$17K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$14K |
| 5 |
Millennium Management
New York
|
-$13.9K |
BDSX Hedge Fund Activity: Q4 2022 in Review
33 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2022, worth a combined $36.9M — up 511% from $6.04M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BDSX positions and 5 closed out — a net gain of 7 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $8.28M. The largest seller was Citadel Advisors, cutting an estimated $34.3K.
- 33 institutional investors held Biodesix (BDSX) as of Q4 2022, up from 27 in Q3 2022.
- Funds reported $36.9M of Biodesix stock for Q4 2022, up 511% quarter-over-quarter.
- 12 funds opened new Biodesix positions in Q4 2022 and 5 closed out, a net change of +7 holders.
- The largest Biodesix buyer in Q4 2022 was AIGH Capital Management, an estimated $8.28M added.
- The largest Biodesix seller in Q4 2022 was Citadel Advisors, an estimated $34.3K sold.
Based on aggregated 13F filings for Q4 2022.